Filing Details

Accession Number:
0001038133-15-000114
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-08-12 17:13:46
Reporting Period:
2015-08-10
Filing Date:
2015-08-12
Accepted Time:
2015-08-12 17:13:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1038133 Heska Corp HSKA Biological Products, (No Disgnostic Substances) (2836) 770192527
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1204126 B Robert Grieve 3760 Rocky Mountain Avenue
Loveland CO 80538
Executive Chair Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-08-10 16,159 $12.50 120,349 No 4 M Direct
Common Stock Disposition 2015-08-10 16,159 $35.08 104,190 No 4 S Direct
Common Stock Disposition 2015-08-10 2,500 $34.90 101,690 No 4 S Direct
Common Stock Acquisiton 2015-08-11 1,106 $12.50 102,796 No 4 M Direct
Common Stock Disposition 2015-08-11 1,106 $35.00 101,690 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-qualified Stock option (right to buy) Disposition 2015-08-10 16,159 $0.00 16,159 $12.50
Common Stock Non-qualified Stock option (right to buy) Disposition 2015-08-11 1,106 $0.00 1,106 $12.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
5,641 2015-12-15 No 4 M Direct
4,535 2015-12-15 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 2,427 Indirect by Daughter I
Common Stock 650 Indirect by Daughter II
Common Stock 1,564 Indirect by Spouse
Footnotes
  1. Includes one share jointly owned with Jason Napolitano.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.21, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.05, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. Gifts under the Uniform Gifts to Minors Act to daughter (Megan Grieve). The reporting person is the custodian of such shares but disclaims beneficial ownership of these shares.
  5. Gifts under the Uniform Gifts to Minors Act to daughter (Madeline Grieve). The reporting person is the custodian of such shares but disclaims beneficial ownership of these shares.
  6. Dr. Grieve disclaims beneficial ownership of all securities of the Issuer owned by his wife.
  7. This option vested in equal monthly installments over four (4) years from the date of grant until it became fully vested on December 15, 2009.